Tamoxifen decreases ovarian toxicity without compromising cancer treatment in a rat model of mammary...
Tamoxifen decreases ovarian toxicity without compromising cancer treatment in a rat model of mammary cancer
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Premenopausal women diagnosed with breast cancer often face aggressive chemotherapy resulting in infertility. Tamoxifen (TAM) is a selective estrogen receptor modulator that was previously suggested as a protective agent against chemotherapy-induced ovarian failure. In the current study, we examined mechanisms of the protective action of TAM in the...
Alternative Titles
Full title
Tamoxifen decreases ovarian toxicity without compromising cancer treatment in a rat model of mammary cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_36bedf37600448b6a8744706a443fbb9
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_36bedf37600448b6a8744706a443fbb9
Other Identifiers
ISSN
1471-2164
E-ISSN
1471-2164
DOI
10.1186/s12864-023-09423-0
